Stay updated on Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.
Latest updates to the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedNew content was added on October 9, 2024, following the deletions that occurred on October 1, 2024.SummaryDifference0.3%
- Check9 days agoChange DetectedThe website has been updated to version 2.11.2 on October 1, 2024, following the removal of version 2.11.0 on August 16, 2024.SummaryDifference1.0%
- Check16 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference4%
- Check23 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check38 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check52 days agoChange DetectedThe website has updated its status from 'Recruiting' to 'Active, not recruiting' as of August 16, 2024.SummaryDifference1%
Stay in the know with updates to Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.